These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3628609)

  • 1. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
    Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R
    Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
    Meltzer HY; Arora RC; Jackman H; Pscheidt G; Smith MD
    Schizophr Bull; 1980; 6(2):213-9. PubMed ID: 7375852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet monoamine oxidase and clinical phenomenology of schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups.
    Wise CD; Bridge TP; Potkin SG; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are paranoid schizophrenics biologically different from other schizophrenics?
    Potkin SG; Cannon HE; Murphy DL; Wyatt RJ
    N Engl J Med; 1978 Jan; 298(2):61-6. PubMed ID: 619236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia.
    Demisch L; von der Mühlen H; Bochnik HJ; Seiler N
    Arch Psychiatr Nervenkr (1970); 1977 Dec; 224(4):319-29. PubMed ID: 606205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics.
    Mann JJ; Kaplan RD; Georgotas A; Friedman E; Branchey M; Gershon S
    Psychopharmacology (Berl); 1981; 74(4):344-8. PubMed ID: 6794079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables.
    Buckman TD; Kling A; Sutphin MS; Steinberg A; Eiduson S
    Psychiatry Res; 1990 Jan; 31(1):1-14. PubMed ID: 1969170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor outcome and low platelet MAO activity in chronic schizophrenia.
    Bierer L; Docherty JP; Young JG; Giller E; Cohen D
    Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cultural study of a biochemical abnormality in paranoid schizophrenia.
    Jeste DV; Doongaji DR; Panjwani D; Datta M; Potkin SG; Karoum F; Thatte S; Sheth AS; Apte JS; Wyatt RJ
    Psychiatry Res; 1981 Dec; 5(3):341-52. PubMed ID: 6948314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
    Karoum F; Potkin S; Chuang LW; Murphy DL; Liebowitz MR; Wyatt RJ
    Biol Psychiatry; 1984 Feb; 19(2):165-78. PubMed ID: 6713036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet MAO activity in schizophrenia and other psychiatric illnesses.
    Sullivan J; Stanfield CN; Dackis C
    Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM
    Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysis.
    Zureick JL; Meltzer HY
    Biol Psychiatry; 1988 May; 24(1):63-78. PubMed ID: 3285902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylethylamine in paranoid chronic schizophrenia.
    Potkin SG; Karoum F; Chuang LW; Cannon-Spoor HE; Phillips I; Wyatt RJ
    Science; 1979 Oct; 206(4417):470-1. PubMed ID: 504988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.